ICOS controls effector function but not trafficking receptor expression of kidney-infiltrating effector T cells in murine lupus

Journal of Immunology

Volumn 182, Issue 7, 2009, Pages 4076-4084

  Odegard, Jared M ^a   DiPlacido, Leah D ^a   Greenwald, Lark ^a   Kashgarian, Michael ^a   Kono, Dwight H ^c   Dong, Chen ^a,d   Flavell, Richard A ^a,b   Craft, Joe ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CHEMOKINE; CHEMOKINE RECEPTOR CXCR3; CXCL9 CHEMOKINE; IMMUNOGLOBULIN G; PADGEM PROTEIN; PROTEIN ICOS; UNCLASSIFIED DRUG; AUTOANTIGEN; CHEMOKINE RECEPTOR CCR5; CXCR3 PROTEIN, MOUSE; CYTOKINE; INDUCIBLE T CELL CO STIMULATOR; INDUCIBLE T-CELL CO-STIMULATOR; T LYMPHOCYTE ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; FEMALE; IMMUNE COMPLEX NEPHRITIS; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE; ANIMAL; B LYMPHOCYTE; BIOSYNTHESIS; BLOOD; CD4+ T LYMPHOCYTE; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; KIDNEY; LYMPHOCYTE ACTIVATION; METABOLISM; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; AUTOANTIBODIES; AUTOANTIGENS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINE CXCL9; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED MRL LPR; MICE, TRANSGENIC; P-SELECTIN; RECEPTORS, CCR5; RECEPTORS, CXCR3;

EID: 64249119894     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0800758     Document Type: Article

References (69)

1. Holman, H. R., and H. G. Kunkel. 1957. Affinity between the lupus erythematosus serum factor and cell nuclei and nucleoprotein. Science 126: 162-163.
2. Kotzin, B. L. 1996. Systemic lupus erythematosus. Cell 85: 303-306.
3. Jevnikar, A. M., M. J. Grusby, and L. H. Glimcher. 1994. Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J. Exp. Med. 179: 1137-1143. (Pubitemid 24091772)
4. Peng, S. L., M. P. Madaio, D. P. Hughes, I. N. Crispe, M. J. Owen, L. Wen, A. C. Hayday, and J. Craft. 1996. Murine lupus in the absence of αβ T cells. J. Immunol. 156: 4041-4049.
5. Chan, O. T., L. G. Hannum, A. M. Haberman, M. P. Madaio, and M. J. Shlomchik. 1999. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J. Exp. Med. 189: 1639-1648.
6. Kelley, V. E., and J. B. Roths. 1985. Interaction of mutant lpr gene with background strain influences renal disease. Clin. Immunol. Immunopathol. 37: 220-229.
7. Schiffer, L., J. Sinha, X. Wang, W. Huang, G. von Gersdorff, M. Schiffer, M. P. Madaio, and A. Davidson. 2003. Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition. J. Immunol. 171: 489-497. (Pubitemid 36745324)
8. Bagavant, H., U. S. Deshmukh, F. Gaskin, and S. M. Fu. 2004. Lupus glomerulonephritis revisited 2004: autoimmunity and end-organ damage. Scand. J. Immunol. 60: 52-63.
9. Peng, S. L., J. Moslehi, and J. Craft. 1997. Roles of interferon-γ and interleukin-4 in murine lupus. J. Clin. Invest. 99: 1936-1946.
10. Peng, S. L., S. J. Szabo, and L. H. Glimcher. 2002. T-bet regulates IgG class switching and pathogenic autoantibody production. Proc. Natl. Acad. Sci. USA 99: 5545-5550.
11. Balomenos, D., R. Rumold, and A. N. Theofilopoulos. 1998. Interferon-γ is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J. Clin. Invest. 101: 364-371. (Pubitemid 28067333)
12. Haas, C., B. Ryffel, and M. Le Hir. 1997. IFN-γ is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice. J. Immunol. 158: 5484-5491. (Pubitemid 127681257)
13. Haas, C., B. Ryffel, and M. Le Hir. 1998. IFN-γ receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW)F1 mice. J. Immunol. 160: 3713-3718. (Pubitemid 28176072)
14. Schwarting, A., T. Wada, K. Kinoshita, G. Tesch, and V. R. Kelley. 1998. IFN-γ receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Faslpr mice. J. Immunol. 161: 494-503. (Pubitemid 28285560)
15. Masutani, K., M. Akahoshi, K. Tsuruya, M. Tokumoto, T. Ninomiya, T. Kohsaka, K. Fukuda, H. Kanai, H. Nakashima, T. Otsuka, and H. Hirakata. 2001. Predominance of Th1 immune response in diffuse proliferative lupus nephritis. Arthritis Rheum. 44: 2097-2106. (Pubitemid 33644053)
16. Hutloff, A., K. Buchner, K. Reiter, H. J. Baelde, M. Odendahl, A. Jacobi, T. Dorner, and R. A. Kroczek. 2004. Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus. Arthritis Rheum. 50: 3211-3220. (Pubitemid 39371998)
17. Massengill, S. F., M. M. Goodenow, and J. W. Sleasman. 1998. SLE nephritis is associated with an oligoclonal expansion of intrarenal T cells. Am. J. Kidney Dis. 31: 418-426.
18. Kashgarian, M. 2002. Lupus nephritis. In Dubois' Lupus Erythematosus. D. J. Wallace and B. H. Hahn, eds. Lippincott Williams & Wilkins, Philadelphia, PA, pp. 1061-1076.
19. Johnston, B., and E. C. Butcher. 2002. Chemokines in rapid leukocyte adhesion triggering and migration. Semin. Immunol. 14: 83-92. (Pubitemid 34879384)
20. lpr mice. J. Exp. Med. 190: 1813-1824.
21. Perez de Lema, G., H. Maier, T. J. Franz, M. Escribese, S. Chilla, S. Segerer, N. Camarasa, H. Schmid, B. Banas, S. Kalaydjiev, D. H. Busch, et al. 2005. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice. J. Am. Soc. Nephrol. 16: 3592-3601.
22. Liu, J., G. Karypis, K. L. Hippen, A. L. Vegoe, P. Ruiz, G. S. Gilkeson, and T. W. Behrens. 2006. Genomic view of systemic autoimmunity in MR/.lpr mice. Genes Immun. 7: 156-168. (Pubitemid 43336058)
23. Kim, C. H., L. Rott, E. J. Kunkel, M. C. Genovese, D. P. Andrew, L. Wu, and E. C. Butcher. 2001. Rules of chemokine receptor association with T cell polarization in vivo. J. Clin. Invest. 108: 1331-1339.
24. Blander, J. M., I. Visintin, C. A. Janeway, Jr., and R. Medzhitov. 1999. α1,3-fucosyltransferase VII and α2,3-sialyltransferase IV are up-regulated in activated CD4 T cells and maintained after their differentiation into Th1 and migration into inflammatory sites. J. Immunol. 163: 3746-3752.
25. Ley, K., and G. S. Kansas. 2004. Selectins in T-cell recruitment to non-lymphoid tissues and sites of inflammation. Nat. Rev. Immunol. 4: 325-335. (Pubitemid 38649275)
26. Segawa, C., T. Wada, M. Takaeda, K. Furuichi, I. Matsuda, Y. Hisada, S. Ohta, K. Takasawa, S. Takeda, K. Kobayashi, and H. Yokoyama. 1997. In situ expression and soluble form of P-selectin in human glomerulonephritis. Kidney Int. 52: 1054-1063. (Pubitemid 27435839)
27. Takaeda, M., H. Yokoyama, C. Segawa-Takaeda, T. Wada, and K. Kobayashi. 2002. High endothelial venule-like vessels in the interstitial lesions of human glomerulonephritis. Am. J. Nephrol. 22: 48-57. (Pubitemid 34264186)
28. Rosenkranz, A. R., D. L. Mendrick, R. S. Cotran, and T. N. Mayadas. 1999. P-selectin deficiency exacerbates experimental glomerulonephritis: a protective role for endothelial P-selectin in inflammation. J. Clin. Invest. 103: 649-659.
29. Wu, T., C. Xie, M. Bhaskarabhatla, M. Yan, A. Leone, S. S. Chen, X. J. Zhou, C. Putterman, and C. Mohan. 2007. Excreted urinary mediators in an animal model of experimental immune nephritis with potential pathogenic significance. Arthritis Rheum. 56: 949-959. (Pubitemid 46399442)
30. Campbell, D. J., C. H. Kim, and E. C. Butcher. 2001. Separable effector T cell populations specialized for B cell help or tissue inflammation. Nat. Immunol. 2: 876-881.
31. Kinoshita, K., G. Tesch, A. Schwarting, R. Maron, A. H. Sharpe, and V. R. Kelley. 2000. Costimulation by B7-1 and B7-2 is required for autoimmune disease in MRL-Faslpr mice. J. Immunol. 164: 6046-6056. (Pubitemid 30389855)
32. Gonzalo, J. A., J. Tian, T. Delaney, J. Corcoran, J. B. Rottman, J. Lora, A. Al-garawi, R. Kroczek, J. C. Gutierrez-Ramos, and A. J. Coyle. 2001. ICOS is critical for T helper cell-mediated lung mucosal inflammatory responses. Nat. Immunol. 2: 597-604.
33. Rottman, J. B., T. Smith, J. R. Tonra, K. Ganley, T. Bloom, R. Silva, B. Pierce, J. C. Gutierrez-Ramos, E. Ozkaynak, and A. J. Coyle. 2001. The costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE. Nat. Immunol. 2: 605-611.
34. Dong, C., A. E. Juedes, U. A. Temann, S. Shresta, J. P. Allison, N. H. Ruddle, and R. A. Flavell. 2001. ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature 409: 97-101. (Pubitemid 32098632)
35. lpr mice. J. Clin. Invest. 101: 696-702.
36. Kong, P. L., T. Zhu, M. P. Madaio, and J. Craft. 2003. Role of the H-2 haplotype in Fas-intact lupus-prone MRL mice: association with autoantibodies but not renal disease. Arthritis Rheum. 48: 2992-2995.
37. Odegard, J. M., B. R. Marks, L. D. DiPlacido, A. C. Poholek, D. H. Kono, C. Dong, R. A. Flavell, and J. Craft. 2008. ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity. J. Exp. Med. 205: 2873-2886.
38. Peng, S. L., S. Fatenejad, and J. Craft. 1996. Induction of nonpathologic, humoral autoimmunity in lupus-prone mice by a class II-restricted, transgenic αβ T cell: separation of autoantigen-specific and -nonspecific help. J. Immunol. 157: 5225-5230.
39. Perez de Lema, G., H. Maier, E. Nieto, V. Vielhauer, B. Luckow, F. Mampaso, and D. Schlondorff. 2001. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J. Am. Soc. Nephrol. 12: 1369-1382. (Pubitemid 32666320)
40. Menke, J., G. C. Zeller, E. Kikawada, T. K. Means, X. R. Huang, H. Y. Lan, B. Lu, J. Farber, A. D. Luster, and V. R. Kelley. 2008. CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease. J. Am. Soc. Nephrol. 19: 1177-1189.
41. Zlotnik, A., and O. Yoshie. 2000. Chemokines: a new classification system and their role in immunity. Immunity 12: 121-127. (Pubitemid 30398626)
42. McAdam, A. J., R. J. Greenwald, M. A. Levin, T. Chernova, N. Malenkovich, V. Ling, G. J. Freeman, and A. H. Sharpe. 2001. ICOS is critical for CD40-mediated antibody class switching. Nature 409: 102-105.
43. Tafuri, A., A. Shahinian, F. Bladt, S. K. Yoshinaga, M. Jordana, A. Wakeham, L. M. Boucher, D. Bouchard, V. S. Chan, G. Duncan, et al. 2001. ICOS is essential for effective T-helper-cell responses. Nature 409: 105-109. (Pubitemid 32098634)
44. Mak, T. W., A. Shahinian, S. K. Yoshinaga, A. Wakeham, L. M. Boucher, M. Pintilie, G. Duncan, B. U. Gajewska, M. Gronski, U. Eriksson, et al. 2003. Costimulation through the inducible costimulator ligand is essential for both T helper and B cell functions in T cell-dependent B cell responses. Nat. Immunol. 4: 765-772.
45. Schall, T. J., J. Jongstra, B. J. Dyer, J. Jorgensen, C. Clayberger, M. M. Davis, and A. M. Krensky. 1988. A human T cell-specific molecule is a member of a new gene family. J. Immunol. 141: 1018-1025.
46. lpr mice. J. Am. Soc. Nephrol. 15: 1504-1513.
47. Nakatani, K., H. Fujii, H. Hasegawa, M. Terada, N. Arita, M. R. Ito, M. Ono, S. Takahashi, K. Saiga, S. Yoshimoto, et al. 2004. Endothelial adhesion molecules in glomerular lesions: association with their severity and diversity in lupus models. Kidney Int. 65: 1290-1300. (Pubitemid 38406967)
48. He, X., T. R. Schoeb, A. Panoskaltsis-Mortari, K. R. Zinn, R. A. Kesterson, J. Zhang, S. Samuel, M. J. Hicks, M. J. Hickey, and D. C. Bullard. 2006. Deficiency of P-selectin or P-selectin glycoprotein ligand-1 leads to accelerated development of glomerulonephritis and increased expression of CC chemokine ligand 2 in lupus-prone mice. J. Immunol. 177: 8748-8756. (Pubitemid 44893841)
49. William, J., C. Euler, S. Christensen, and M. J. Shlomchik. 2002. Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science 297: 2066-2070.
50. Iwai, H., M. Abe, S. Hirose, F. Tsushima, K. Tezuka, H. Akiba, H. Yagita, K. Okumura, H. Kohsaka, N. Miyasaka, and M. Azuma. 2003. Involvement of inducible costimulator-B7 homologous protein costimulatory pathway in murine lupus nephritis. J. Immunol. 171: 2848-2854. (Pubitemid 37093504)
51. lpr mice: uncoupling of autoantibodies and T cell responses in lupus. J. Am. Soc. Nephrol. 17: 122-130.
52. Yoshinaga, S. K., J. S. Whoriskey, S. D. Khare, U. Sarmiento, J. Guo, T. Horan, G. Shih, M. Zhang, M. A. Coccia, T. Kohno, et al. 1999. T-cell co-stimulation through B7RP-1 and ICOS. Nature 402: 827-832. (Pubitemid 129638129)
53. Greenwald, R. J., A. J. McAdam, D. Van der Woude, A. R. Satoskar, and A. H. Sharpe. 2002. Cutting edge: inducible costimulator protein regulates both Th1 and Th2 responses to cutaneous leishmaniasis. J. Immunol. 168: 991-995.
54. Tesciuba, A. G., S. Subudhi, R. P. Rother, S. J. Faas, A. M. Frantz, D. Elliot, J. Weinstock, L. A. Matis, J. A. Bluestone, and A. I. Sperling. 2001. Inducible costimulator regulates Th2-mediated inflammation, but not Th2 differentiation, in a model of allergic airway disease. J. Immunol. 167: 1996-2003.
55. Wiley, R. E., S. Goncharova, T. Shea, J. R. Johnson, A. J. Coyle, and M. Jordana. 2003. Evaluation of inducible costimulator/B7-related protein-1 as a therapeutic target in a murine model of allergic airway inflammation. Am. J. Respir. Cell Mol. Biol. 28: 722-730. (Pubitemid 36677176)
56. Iwai, H., Y. Kozono, S. Hirose, H. Akiba, H. Yagita, K. Okumura, H. Kohsaka, N. Miyasaka, and M. Azuma. 2002. Amelioration of collagen-induced arthritis by blockade of inducible costimulator-B7 homologous protein costimulation. J. Immunol. 169: 4332-4339. (Pubitemid 35178206)
57. Kashizuka, H., M. Sho, T. Nomi, N. Ikeda, Y. Kuzumoto, S. Akashi, Y. Tsurui, T. Mizuno, H. Kanehiro, H. Yagita, Y. Nakajima, and M. H. Sayegh. 2005. Role of the ICOS-B7h costimulatory pathway in the pathophysiology of chronic allograft rejection. Transplantation 79: 1045-1050. (Pubitemid 40663995)
58. Clynes, R., C. Dumitru, and J. V. Ravetch. 1998. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279: 1052-1054. (Pubitemid 28113310)
59. Vielhauer, V., H. J. Anders, and D. Schlondorff. 2007. Chemokines and chemokine receptors as therapeutic targets in lupus nephritis. Semin. Nephrol. 27: 81-97. (Pubitemid 46320753)
60. lpr kidneys are dependent on multiple T-cell subsets. Kidney Int. 59: 565-578.
61. Diaz Gallo, C., A. M. Jevnikar, D. C. Brennan, S. Florquin, A. Pacheco-Silva, and V. R. Kelley. 1992. Autoreactive kidney-infiltrating T-cell clones in murine lupus nephritis. Kidney Int. 42: 851-859.
62. + T-cell trafficking. Blood 106: 3432-3439.
63. Nurieva, R. I., X. M. Mai, K. Forbush, M. J. Bevan, and C. Dong. 2003. B7h is required for T cell activation, differentiation, and effector function. Proc. Natl. Acad. Sci. USA 100: 14163-14168. (Pubitemid 37499208)
64. Wahl, P., R. Schoop, G. Bilic, J. Neuweiler, M. Le Hir, S. K. Yoshinaga, and R. P. Wuthrich. 2002. Renal tubular epithelial expression of the costimulatory molecule B7RP-1 (inducible costimulator ligand). J. Am. Soc. Nephrol. 13: 1517-1526. (Pubitemid 34579241)
65. Arimura, Y., H. Kato, U. Dianzani, T. Okamoto, S. Kamekura, D. Buonfiglio, T. Miyoshi-Akiyama, T. Uchiyama, and J. Yagi. 2002. A co-stimulatory molecule on activated T cells, H4/ICOS, delivers specific signals in Th cells and regulates their responses. Int. Immunol. 14: 555-566. (Pubitemid 34649711)
66. Fruman, D. A. 2004. Phosphoinositide 3-kinase and its targets in B-cell and T-cell signaling. Curr. Opin. Immunol. 16: 314-320.
67. Jeruc, J., V. Jurcic, A. Vizjak, A. Hvala, N. Babic, R. Kveder, S. Praprotnik, and D. Ferluga. 2000. Tubulo-interstitial involvement in lupus nephritis with emphasis on pathogenesis. Wien Klin. Wochenschr. 112: 702-706.
68. Segerer, S., B. Banas, M. Wornle, H. Schmid, C. D. Cohen, M. Kretzler, M. Mack, E. Kiss, P. J. Nelson, D. Schlondorff, and H. J. Grone. 2004. CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis. Am. J. Pathol. 164: 635-649. (Pubitemid 38364678)
69. + T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients. Arthritis Rheum. 60: 199-206.